U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07311278) titled 'Identification of Sentinel Lymph Nodes Using Indocyanine Green in Breast Cancer Patients' on Nov. 26.
Brief Summary: This study aims to evaluate the (inter)national implementation of a new diagnostic method for sentinel lymph node (SLN) detection in breast cancer. While Technetium-99m (99mTc) is the current gold standard for SLN detection, it has drawbacks such as limited availability, logistical challenges, radiation exposure, and potential side effects. Extensive research indicates that Indocyanine Green (ICG) is an equally effective and potentially more practical alternative. Conducting this study will help accelerate the impleme...